Thrombin increases the release of fibronectin by MDSCs at both the mRNA and protein levels [55], and the catalytic activity of thrombin leads to the release of the mature form of TGF-β1 from platelets, resulting in cancer immune evasion [56]. This evidence concerns the gene TGFB1 and cancer.